Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 Edaravone Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global Edaravone Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Edaravone Market Performance
• 2.3 USA Edaravone Market Performance
• 2.4 Europe Edaravone Market Performance
• 2.5 Japan Edaravone Market Performance
• 2.6 Korea Edaravone Market Performance
• 2.7 India Edaravone Market Performance
• 2.8 Southeast Asia Edaravone Market Performance
• 2.9 South America Edaravone Market Performance

3 Global Edaravone Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China Edaravone Market Performance (Volume)
• 3.3 USA Edaravone Market Performance (Volume)
• 3.4 Europe Edaravone Market Performance (Volume)
• 3.5 Japan Edaravone Market Performance (Volume)
• 3.6 Korea Edaravone Market Performance (Volume)
• 3.7 India Edaravone Market Performance (Volume)
• 3.8 Southeast Asia Edaravone Market Performance (Volume)
• 3.9 South America Edaravone Market Performance (Volume)

4 Competitive Analysis

• 4.1 Mitsubishi Tanabe Pharma
  • 4.1.1 Mitsubishi Tanabe Pharma Profiles
  • 4.1.2 Mitsubishi Tanabe Pharma Product Information
  • 4.1.3 Mitsubishi Tanabe Pharma Edaravone Production, Revenue, Price and Gross Margin
  • 4.1.4 Mitsubishi Tanabe Pharma Edaravone Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 Simcere
  • 4.2.1 Simcere Profiles
  • 4.2.2 Simcere Product Information
  • 4.2.3 Simcere Edaravone Production, Revenue, Price and Gross Margin
  • 4.2.4 Simcere Edaravone Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Taj Pharmaceuticals Ltd.
  • 4.3.1 Taj Pharmaceuticals Ltd. Profiles
  • 4.3.2 Taj Pharmaceuticals Ltd. Product Information
  • 4.3.3 Taj Pharmaceuticals Ltd. Edaravone Production, Revenue, Price and Gross Margin
  • 4.3.4 Taj Pharmaceuticals Ltd. Edaravone Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 Sun Pharmaceutical Industries Ltd.
  • 4.4.1 Sun Pharmaceutical Industries Ltd. Profiles
  • 4.4.2 Sun Pharmaceutical Industries Ltd. Product Information
  • 4.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Production, Revenue, Price and Gross Margin
  • 4.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 Unichem Laboratories Ltd
  • 4.5.1 Unichem Laboratories Ltd Profiles
  • 4.5.2 Unichem Laboratories Ltd Product Information
  • 4.5.3 Unichem Laboratories Ltd Edaravone Production, Revenue, Price and Gross Margin
  • 4.5.4 Unichem Laboratories Ltd Edaravone Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 UCB India Ltd
  • 4.6.1 UCB India Ltd Profiles
  • 4.6.2 UCB India Ltd Product Information
  • 4.6.3 UCB India Ltd Edaravone Production, Revenue, Price and Gross Margin
  • 4.6.4 UCB India Ltd Edaravone Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Piramal Healthcare
  • 4.7.1 Piramal Healthcare Profiles
  • 4.7.2 Piramal Healthcare Product Information
  • 4.7.3 Piramal Healthcare Edaravone Production, Revenue, Price and Gross Margin
  • 4.7.4 Piramal Healthcare Edaravone Business Performance
  • 4.7.5 SWOT Analysis

5 Competitive Landscape

• 5.1 Global Edaravone Production (K Units) and Market Share by Manufacturers (2014-2019)
• 5.2 Global Edaravone Revenue (M USD) and Market Share by Manufacturers (2014-2019)
• 5.3 Global Edaravone Price (USD/Unit) of Manufacturers (2014-2019)
• 5.4 Global Edaravone Gross Margin of Manufacturers (2014-2019)
• 5.5 Market Concentration

6 Global Edaravone Market Assessment by Regions

• 6.1 Global Edaravone Production (K Units) and Market Share by Regions (2014-2019)
• 6.2 Global Edaravone Revenue (M USD) and Market Share by Regions (2014-2019)
• 6.3 Global Edaravone Price (USD/Unit) by Regions (2014-2019)
• 6.4 Global Edaravone Gross Margin by Regions (2014-2019)

7 Edaravone Regional Analysis

• 7.1 China Edaravone Production, Revenue and Growth Rate (2014-2019)
• 7.2 USA Edaravone Production, Revenue and Growth Rate (2014-2019)
• 7.3 Europe Edaravone Production, Revenue and Growth Rate (2014-2019)
• 7.4 Japan Edaravone Production, Revenue and Growth Rate (2014-2019)
• 7.5 Korea Edaravone Production, Revenue and Growth Rate (2014-2019)
• 7.6 India Edaravone Production, Revenue and Growth Rate (2014-2019)
• 7.7 Southeast Asia Edaravone Production, Revenue and Growth Rate (2014-2019)
• 7.8 South America Edaravone Production, Revenue and Growth Rate (2014-2019)

8 Global Edaravone Consumption Assessment

• 8.1 Global Edaravone Consumption and Market Share by Regions (2014-2019)
• 8.2 Global Edaravone Consumption Value and Market Share by Regions (2014-2019)
• 8.3 Global Edaravone Average Price (USD/Unit) by Regions (2014-2019)

9 Global Edaravone Sales Assessment by Regions

• 9.1 Global Edaravone Sales and Sales Value (2014-2019)
• 9.2 China Edaravone Sales and Sales Value (2014-2019)
• 9.3 USA Edaravone Sales and Sales Value (2014-2019)
• 9.4 Europe Edaravone Sales and Sales Value (2014-2019)
• 9.5 Japan Edaravone Sales and Sales Value (2014-2019)
• 9.6 Korea Edaravone Sales and Sales Value (2014-2019)
• 9.7 India Edaravone Sales and Sales Value (2014-2019)
• 9.8 Southeast Asia Edaravone Sales and Sales Value (2014-2019)
• 9.9 South America Edaravone Sales and Sales Value (2014-2019)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2020-2025

• 12.1 Production and Revenue Forecast 2020-2025
  • 12.1.1 Global Edaravone Production and Revenue by Regions 2020-2025
  • 12.1.2 China Edaravone Production, Revenue and Growth Rate 2020-2025
  • 12.1.3 USA Edaravone Production, Revenue and Growth Rate 2020-2025
  • 12.1.4 Europe Edaravone Production, Revenue and Growth Rate 2020-2025
  • 12.1.5 Japan Edaravone Production, Revenue and Growth Rate 2020-2025
  • 12.1.6 Korea Edaravone Production, Revenue and Growth Rate 2020-2025
  • 12.1.7 India Edaravone Production, Revenue and Growth Rate 2020-2025
  • 12.1.8 Southeast Asia Edaravone Production, Revenue and Growth Rate 2020-2025
  • 12.1.9 South America Edaravone Production, Revenue and Growth Rate 2020-2025
• 12.2 Sales and Sales Value Forecast 2020-2025
  • 12.2.1 Global Edaravone Consumption and Consumption Calue by Regions 2020-2025
  • 12.2.2 Global Edaravone Sales and Sales Value Forecast 2020-2025
  • 12.2.3 China Edaravone Sales, Sales Value and Growth Rate 2020-2025
  • 12.2.4 USA Edaravone Sales and Sales Value Forecast 2020-2025
  • 12.2.5 Europe Edaravone Sales and Sales Value Forecast 2020-2025
  • 12.2.6 Japan Edaravone Sales and Sales Value Forecast 2020-2025
  • 12.2.7 Korea Edaravone Sales and Sales Value Forecast 2020-2025
  • 12.2.8 India Edaravone Sales and Sales Value Forecast 2020-2025
  • 12.2.9 Southeast Asia Edaravone Sales and Sales Value Forecast 2020-2025
  • 12.2.10 South America Edaravone Sales and Sales Value Forecast 2020-2025
• 12.3 Global Edaravone Production and Revenue Forecast by Type 2020-2025
  • 12.3.1 Overall Market Performance
  • 12.3.2 Oral
  • 12.3.3 Injection
• 12.4 Global Edaravone Sales Forecast by Application 2020-2025
  • 12.4.1 Overall Market Performance
  • 12.4.2 Hospital
  • 12.4.3 Clinic
  • 12.4.4 Others
• 12.5 Global Edaravone Price and Gross Margin Forecast
  • 13.5.1 Global Edaravone Averages Price Development Trend Forecast 2020-2025
  • 13.5.2 Global Edaravone Gross Margin Development Trend Forecast 2020-2025

13 Conclusion

Geographically, global Edaravone market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare

On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Oral
Injection
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Edaravone for each application, including
Hospital
Clinic
Others
Production, consumption, revenue, market share and growth rate are the key targets for Edaravone from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.